Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Branched-chain Aminoacids in Sleep Apnea Syndromes
NCT01115686Phase 3Withdrawn
- Sponsor
- CHU de Limoges
- Start
- Jun 2010
- Primary completion
- Jun 2012
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of Branchamin in sleep apnea syndrome (SAS), sponsored by CHU de Limoges. Planned start Jun 2010; status: withdrawn.
02
Drugs
Branchamin
03
Conditions
sleep apnea syndrome (SAS)
Beyond the preview
Go deeper on NCT01115686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01115686.